药物靶标开发中涉及的专利问题分析  

Patent issues involved in the development of drug targets

作　　者：张音[1] 王松俊[1] 刁天喜[1] 楼铁柱[1] 

机构地区：[1]军事医学科学院卫生勤务与医学情报研究所,北京100850

出　　处：《中国新药杂志》2009年第10期872-875,共4页Chinese Journal of New Drugs

基　　金：国家863项目(2006AA02Z316)

摘　　要：现代各种组学和高通量筛选技术为人们带来了大量潜在的药物靶标。生物制药公司和研发机构为保证在药物靶标的开发中获得最大限度的投资回报,往往对药物靶标申请专利保护。尽管如此,药物靶标开发中仍然有许多专利问题尚未明确。本文采用定性与定量的研究方法,对药物靶标开发中涉及的问题进行分析,并提出我国应采取的药物靶标专利策略。Modern omics and high-throughput screening technologies bring a great deal of potential drug targets. Biopharmaceutical companies and research institutions often apply patent protection for potential drug targets in order to ensure the maximal return of investment. Nevertheless, many problems related to patent issues had not yet clear. In this paper, these problems with qualitative and quantitative research methods were analyzed, and some suggestions were provided for suitable patent strategy in China.

关 键 词：药物靶标 开发 专利问题 

分 类 号：R95[医药卫生—药学]